Rhythm Pharmaceuticals, Inc. (RYTM)
104.85
-0.57
(-0.54%)
USD |
NASDAQ |
Sep 03, 16:00
104.85
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Cash and Short Term Investments (Quarterly) : 330.90M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 330.90M |
| March 31, 2026 | 340.62M |
| December 31, 2025 | 388.95M |
| September 30, 2025 | 416.05M |
| June 30, 2025 | 291.03M |
| March 31, 2025 | 314.49M |
| December 31, 2024 | 320.56M |
| September 30, 2024 | 298.39M |
| June 30, 2024 | 319.13M |
| March 31, 2024 | 201.20M |
| December 31, 2023 | 275.85M |
| September 30, 2023 | 299.26M |
| June 30, 2023 | 253.60M |
| March 31, 2023 | 294.58M |
| December 31, 2022 | 333.29M |
| September 30, 2022 | 347.80M |
| June 30, 2022 | 235.60M |
| March 31, 2022 | 240.96M |
| December 31, 2021 | 294.86M |
| September 30, 2021 | 328.35M |
| June 30, 2021 | 368.15M |
| March 31, 2021 | 404.75M |
| December 31, 2020 | 172.79M |
| September 30, 2020 | 201.78M |
| June 30, 2020 | 228.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 257.42M |
| December 31, 2019 | 292.46M |
| September 30, 2019 | 162.44M |
| June 30, 2019 | 195.17M |
| March 31, 2019 | 221.52M |
| December 31, 2018 | 252.06M |
| September 30, 2018 | 272.39M |
| June 30, 2018 | 287.55M |
| March 31, 2018 | 136.45M |
| December 31, 2017 | 148.08M |
| September 30, 2017 | 30.42M |
| June 30, 2017 | 17.74M |
| March 31, 2017 | 23.88M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 34.87M |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 0.152M |
| September 30, 2014 | |
| June 30, 2014 | 9.333M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| BioMarin Pharmaceutical, Inc. | 874.00M |
| Cytokinetics, Inc. | 1.169B |
| Exelixis, Inc. | 839.38M |